ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intelligent Cancer Care (ICC) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29Z14460
Home | Market Reports | Health| Health Conditions| Cancer
Global Intelligent Cancer Care ICC Market Research Report 2023
BUY CHAPTERS

Global Intelligent Cancer Care (ICC) Market Research Report 2025

Code: QYRE-Auto-29Z14460
Report
May 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Varian (Siemens)
Canon Inc
Sophia Genetics
Freenome
GSK
Roche
Exscientia Ltd
BenevolentAI
Bayer
Philips
GE Healthcare
Azra AI
Path AI
NVidia
Digital Diagnostics
Median Technologies
BioNTech SE
CityCancerChallenge
VieCure
ConcertAI
Sanofi
Pfizer Inc
IBM

Intelligent Cancer Care (ICC) Market Size

The global market for Intelligent Cancer Care (ICC) was valued at US$ 1339 million in the year 2024 and is projected to reach a revised size of US$ 7444 million by 2031, growing at a CAGR of 28.2% during the forecast period.

Intelligent Cancer Care (ICC) Market

Intelligent Cancer Care (ICC) Market

Intelligent Cancer Care (ICC) is kind of information-driven network of next generation oncology solutions that bring people, data, and technology together to manage a more intelligent approach to cancer care.
North American market for Intelligent Cancer Care (ICC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Intelligent Cancer Care (ICC) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Intelligent Cancer Care (ICC) in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Intelligent Cancer Care (ICC) include Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM, Sanofi, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intelligent Cancer Care (ICC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Cancer Care (ICC).
The Intelligent Cancer Care (ICC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intelligent Cancer Care (ICC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intelligent Cancer Care (ICC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intelligent Cancer Care (ICC) Market Report

Report Metric Details
Report Name Intelligent Cancer Care (ICC) Market
Accounted market size in year US$ 1339 million
Forecasted market size in 2031 US$ 7444 million
CAGR 28.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM, Sanofi, GSK, Roche, Exscientia, BenevolentAI, Bayer, Philips, GE Healthcare, Azra AI, Path AI, NVIDIA, ConcertAI, Digital Diagnostics, Median Technologies, BioNTech SE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intelligent Cancer Care (ICC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Intelligent Cancer Care (ICC) Market growing?

Ans: The Intelligent Cancer Care (ICC) Market witnessing a CAGR of 28.2% during the forecast period 2025-2031.

What is the Intelligent Cancer Care (ICC) Market size in 2031?

Ans: The Intelligent Cancer Care (ICC) Market size in 2031 will be US$ 7444 million.

Who are the main players in the Intelligent Cancer Care (ICC) Market report?

Ans: The main players in the Intelligent Cancer Care (ICC) Market are Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM, Sanofi, GSK, Roche, Exscientia, BenevolentAI, Bayer, Philips, GE Healthcare, Azra AI, Path AI, NVIDIA, ConcertAI, Digital Diagnostics, Median Technologies, BioNTech SE

What are the Application segmentation covered in the Intelligent Cancer Care (ICC) Market report?

Ans: The Applications covered in the Intelligent Cancer Care (ICC) Market report are Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others

What are the Type segmentation covered in the Intelligent Cancer Care (ICC) Market report?

Ans: The Types covered in the Intelligent Cancer Care (ICC) Market report are Cancer Prevention and Screening, AI-Assisted Diagnosis, Prediction of Treatment Outcome, Intelligent Radiation Oncology, Tele-Oncology

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

AI in Oncology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intelligent Cancer Care (ICC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer Prevention and Screening
1.2.3 AI-Assisted Diagnosis
1.2.4 Prediction of Treatment Outcome
1.2.5 Intelligent Radiation Oncology
1.2.6 Tele-Oncology
1.3 Market by Application
1.3.1 Global Intelligent Cancer Care (ICC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colorectal Cancer
1.3.6 Brain Tumor
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intelligent Cancer Care (ICC) Market Perspective (2020-2031)
2.2 Global Intelligent Cancer Care (ICC) Growth Trends by Region
2.2.1 Global Intelligent Cancer Care (ICC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intelligent Cancer Care (ICC) Historic Market Size by Region (2020-2025)
2.2.3 Intelligent Cancer Care (ICC) Forecasted Market Size by Region (2026-2031)
2.3 Intelligent Cancer Care (ICC) Market Dynamics
2.3.1 Intelligent Cancer Care (ICC) Industry Trends
2.3.2 Intelligent Cancer Care (ICC) Market Drivers
2.3.3 Intelligent Cancer Care (ICC) Market Challenges
2.3.4 Intelligent Cancer Care (ICC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intelligent Cancer Care (ICC) Players by Revenue
3.1.1 Global Top Intelligent Cancer Care (ICC) Players by Revenue (2020-2025)
3.1.2 Global Intelligent Cancer Care (ICC) Revenue Market Share by Players (2020-2025)
3.2 Global Intelligent Cancer Care (ICC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intelligent Cancer Care (ICC) Revenue
3.4 Global Intelligent Cancer Care (ICC) Market Concentration Ratio
3.4.1 Global Intelligent Cancer Care (ICC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intelligent Cancer Care (ICC) Revenue in 2024
3.5 Global Key Players of Intelligent Cancer Care (ICC) Head office and Area Served
3.6 Global Key Players of Intelligent Cancer Care (ICC), Product and Application
3.7 Global Key Players of Intelligent Cancer Care (ICC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intelligent Cancer Care (ICC) Breakdown Data by Type
4.1 Global Intelligent Cancer Care (ICC) Historic Market Size by Type (2020-2025)
4.2 Global Intelligent Cancer Care (ICC) Forecasted Market Size by Type (2026-2031)
5 Intelligent Cancer Care (ICC) Breakdown Data by Application
5.1 Global Intelligent Cancer Care (ICC) Historic Market Size by Application (2020-2025)
5.2 Global Intelligent Cancer Care (ICC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intelligent Cancer Care (ICC) Market Size (2020-2031)
6.2 North America Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intelligent Cancer Care (ICC) Market Size by Country (2020-2025)
6.4 North America Intelligent Cancer Care (ICC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intelligent Cancer Care (ICC) Market Size (2020-2031)
7.2 Europe Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intelligent Cancer Care (ICC) Market Size by Country (2020-2025)
7.4 Europe Intelligent Cancer Care (ICC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intelligent Cancer Care (ICC) Market Size (2020-2031)
8.2 Asia-Pacific Intelligent Cancer Care (ICC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intelligent Cancer Care (ICC) Market Size (2020-2031)
9.2 Latin America Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intelligent Cancer Care (ICC) Market Size by Country (2020-2025)
9.4 Latin America Intelligent Cancer Care (ICC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intelligent Cancer Care (ICC) Market Size (2020-2031)
10.2 Middle East & Africa Intelligent Cancer Care (ICC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Varian (Siemens)
11.1.1 Varian (Siemens) Company Details
11.1.2 Varian (Siemens) Business Overview
11.1.3 Varian (Siemens) Intelligent Cancer Care (ICC) Introduction
11.1.4 Varian (Siemens) Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.1.5 Varian (Siemens) Recent Development
11.2 CityCancerChallenge
11.2.1 CityCancerChallenge Company Details
11.2.2 CityCancerChallenge Business Overview
11.2.3 CityCancerChallenge Intelligent Cancer Care (ICC) Introduction
11.2.4 CityCancerChallenge Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.2.5 CityCancerChallenge Recent Development
11.3 Canon
11.3.1 Canon Company Details
11.3.2 Canon Business Overview
11.3.3 Canon Intelligent Cancer Care (ICC) Introduction
11.3.4 Canon Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.3.5 Canon Recent Development
11.4 VieCure
11.4.1 VieCure Company Details
11.4.2 VieCure Business Overview
11.4.3 VieCure Intelligent Cancer Care (ICC) Introduction
11.4.4 VieCure Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.4.5 VieCure Recent Development
11.5 Sophia Genetics
11.5.1 Sophia Genetics Company Details
11.5.2 Sophia Genetics Business Overview
11.5.3 Sophia Genetics Intelligent Cancer Care (ICC) Introduction
11.5.4 Sophia Genetics Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.5.5 Sophia Genetics Recent Development
11.6 Freenome
11.6.1 Freenome Company Details
11.6.2 Freenome Business Overview
11.6.3 Freenome Intelligent Cancer Care (ICC) Introduction
11.6.4 Freenome Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.6.5 Freenome Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Intelligent Cancer Care (ICC) Introduction
11.7.4 Pfizer Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 IBM
11.8.1 IBM Company Details
11.8.2 IBM Business Overview
11.8.3 IBM Intelligent Cancer Care (ICC) Introduction
11.8.4 IBM Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.8.5 IBM Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Intelligent Cancer Care (ICC) Introduction
11.9.4 Sanofi Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Intelligent Cancer Care (ICC) Introduction
11.10.4 GSK Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.10.5 GSK Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Intelligent Cancer Care (ICC) Introduction
11.11.4 Roche Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.11.5 Roche Recent Development
11.12 Exscientia
11.12.1 Exscientia Company Details
11.12.2 Exscientia Business Overview
11.12.3 Exscientia Intelligent Cancer Care (ICC) Introduction
11.12.4 Exscientia Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.12.5 Exscientia Recent Development
11.13 BenevolentAI
11.13.1 BenevolentAI Company Details
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI Intelligent Cancer Care (ICC) Introduction
11.13.4 BenevolentAI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.13.5 BenevolentAI Recent Development
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Intelligent Cancer Care (ICC) Introduction
11.14.4 Bayer Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.14.5 Bayer Recent Development
11.15 Philips
11.15.1 Philips Company Details
11.15.2 Philips Business Overview
11.15.3 Philips Intelligent Cancer Care (ICC) Introduction
11.15.4 Philips Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.15.5 Philips Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Intelligent Cancer Care (ICC) Introduction
11.16.4 GE Healthcare Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.16.5 GE Healthcare Recent Development
11.17 Azra AI
11.17.1 Azra AI Company Details
11.17.2 Azra AI Business Overview
11.17.3 Azra AI Intelligent Cancer Care (ICC) Introduction
11.17.4 Azra AI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.17.5 Azra AI Recent Development
11.18 Path AI
11.18.1 Path AI Company Details
11.18.2 Path AI Business Overview
11.18.3 Path AI Intelligent Cancer Care (ICC) Introduction
11.18.4 Path AI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.18.5 Path AI Recent Development
11.19 NVIDIA
11.19.1 NVIDIA Company Details
11.19.2 NVIDIA Business Overview
11.19.3 NVIDIA Intelligent Cancer Care (ICC) Introduction
11.19.4 NVIDIA Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.19.5 NVIDIA Recent Development
11.20 ConcertAI
11.20.1 ConcertAI Company Details
11.20.2 ConcertAI Business Overview
11.20.3 ConcertAI Intelligent Cancer Care (ICC) Introduction
11.20.4 ConcertAI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.20.5 ConcertAI Recent Development
11.21 Digital Diagnostics
11.21.1 Digital Diagnostics Company Details
11.21.2 Digital Diagnostics Business Overview
11.21.3 Digital Diagnostics Intelligent Cancer Care (ICC) Introduction
11.21.4 Digital Diagnostics Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.21.5 Digital Diagnostics Recent Development
11.22 Median Technologies
11.22.1 Median Technologies Company Details
11.22.2 Median Technologies Business Overview
11.22.3 Median Technologies Intelligent Cancer Care (ICC) Introduction
11.22.4 Median Technologies Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.22.5 Median Technologies Recent Development
11.23 BioNTech SE
11.23.1 BioNTech SE Company Details
11.23.2 BioNTech SE Business Overview
11.23.3 BioNTech SE Intelligent Cancer Care (ICC) Introduction
11.23.4 BioNTech SE Revenue in Intelligent Cancer Care (ICC) Business (2020-2025)
11.23.5 BioNTech SE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Varian (Siemens)
Canon Inc
Sophia Genetics
Freenome
GSK
Roche
Exscientia Ltd
BenevolentAI
Bayer
Philips
GE Healthcare
Azra AI
Path AI
NVidia
Digital Diagnostics
Median Technologies
BioNTech SE
CityCancerChallenge
VieCure
ConcertAI
Sanofi
Pfizer Inc
IBM
List of Tables
 Table 1. Global Intelligent Cancer Care (ICC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cancer Prevention and Screening
 Table 3. Key Players of AI-Assisted Diagnosis
 Table 4. Key Players of Prediction of Treatment Outcome
 Table 5. Key Players of Intelligent Radiation Oncology
 Table 6. Key Players of Tele-Oncology
 Table 7. Global Intelligent Cancer Care (ICC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Intelligent Cancer Care (ICC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Intelligent Cancer Care (ICC) Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Intelligent Cancer Care (ICC) Market Share by Region (2020-2025)
 Table 11. Global Intelligent Cancer Care (ICC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Intelligent Cancer Care (ICC) Market Share by Region (2026-2031)
 Table 13. Intelligent Cancer Care (ICC) Market Trends
 Table 14. Intelligent Cancer Care (ICC) Market Drivers
 Table 15. Intelligent Cancer Care (ICC) Market Challenges
 Table 16. Intelligent Cancer Care (ICC) Market Restraints
 Table 17. Global Intelligent Cancer Care (ICC) Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Intelligent Cancer Care (ICC) Market Share by Players (2020-2025)
 Table 19. Global Top Intelligent Cancer Care (ICC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Cancer Care (ICC) as of 2024)
 Table 20. Ranking of Global Top Intelligent Cancer Care (ICC) Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Intelligent Cancer Care (ICC) Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Intelligent Cancer Care (ICC), Headquarters and Area Served
 Table 23. Global Key Players of Intelligent Cancer Care (ICC), Product and Application
 Table 24. Global Key Players of Intelligent Cancer Care (ICC), Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Intelligent Cancer Care (ICC) Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Intelligent Cancer Care (ICC) Revenue Market Share by Type (2020-2025)
 Table 28. Global Intelligent Cancer Care (ICC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Intelligent Cancer Care (ICC) Revenue Market Share by Type (2026-2031)
 Table 30. Global Intelligent Cancer Care (ICC) Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Intelligent Cancer Care (ICC) Revenue Market Share by Application (2020-2025)
 Table 32. Global Intelligent Cancer Care (ICC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Intelligent Cancer Care (ICC) Revenue Market Share by Application (2026-2031)
 Table 34. North America Intelligent Cancer Care (ICC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Intelligent Cancer Care (ICC) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Intelligent Cancer Care (ICC) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Intelligent Cancer Care (ICC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Intelligent Cancer Care (ICC) Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Intelligent Cancer Care (ICC) Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Intelligent Cancer Care (ICC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Intelligent Cancer Care (ICC) Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Intelligent Cancer Care (ICC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Intelligent Cancer Care (ICC) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Intelligent Cancer Care (ICC) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Intelligent Cancer Care (ICC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Varian (Siemens) Company Details
 Table 50. Varian (Siemens) Business Overview
 Table 51. Varian (Siemens) Intelligent Cancer Care (ICC) Product
 Table 52. Varian (Siemens) Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 53. Varian (Siemens) Recent Development
 Table 54. CityCancerChallenge Company Details
 Table 55. CityCancerChallenge Business Overview
 Table 56. CityCancerChallenge Intelligent Cancer Care (ICC) Product
 Table 57. CityCancerChallenge Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 58. CityCancerChallenge Recent Development
 Table 59. Canon Company Details
 Table 60. Canon Business Overview
 Table 61. Canon Intelligent Cancer Care (ICC) Product
 Table 62. Canon Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 63. Canon Recent Development
 Table 64. VieCure Company Details
 Table 65. VieCure Business Overview
 Table 66. VieCure Intelligent Cancer Care (ICC) Product
 Table 67. VieCure Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 68. VieCure Recent Development
 Table 69. Sophia Genetics Company Details
 Table 70. Sophia Genetics Business Overview
 Table 71. Sophia Genetics Intelligent Cancer Care (ICC) Product
 Table 72. Sophia Genetics Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 73. Sophia Genetics Recent Development
 Table 74. Freenome Company Details
 Table 75. Freenome Business Overview
 Table 76. Freenome Intelligent Cancer Care (ICC) Product
 Table 77. Freenome Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 78. Freenome Recent Development
 Table 79. Pfizer Company Details
 Table 80. Pfizer Business Overview
 Table 81. Pfizer Intelligent Cancer Care (ICC) Product
 Table 82. Pfizer Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 83. Pfizer Recent Development
 Table 84. IBM Company Details
 Table 85. IBM Business Overview
 Table 86. IBM Intelligent Cancer Care (ICC) Product
 Table 87. IBM Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 88. IBM Recent Development
 Table 89. Sanofi Company Details
 Table 90. Sanofi Business Overview
 Table 91. Sanofi Intelligent Cancer Care (ICC) Product
 Table 92. Sanofi Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 93. Sanofi Recent Development
 Table 94. GSK Company Details
 Table 95. GSK Business Overview
 Table 96. GSK Intelligent Cancer Care (ICC) Product
 Table 97. GSK Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 98. GSK Recent Development
 Table 99. Roche Company Details
 Table 100. Roche Business Overview
 Table 101. Roche Intelligent Cancer Care (ICC) Product
 Table 102. Roche Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 103. Roche Recent Development
 Table 104. Exscientia Company Details
 Table 105. Exscientia Business Overview
 Table 106. Exscientia Intelligent Cancer Care (ICC) Product
 Table 107. Exscientia Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 108. Exscientia Recent Development
 Table 109. BenevolentAI Company Details
 Table 110. BenevolentAI Business Overview
 Table 111. BenevolentAI Intelligent Cancer Care (ICC) Product
 Table 112. BenevolentAI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 113. BenevolentAI Recent Development
 Table 114. Bayer Company Details
 Table 115. Bayer Business Overview
 Table 116. Bayer Intelligent Cancer Care (ICC) Product
 Table 117. Bayer Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 118. Bayer Recent Development
 Table 119. Philips Company Details
 Table 120. Philips Business Overview
 Table 121. Philips Intelligent Cancer Care (ICC) Product
 Table 122. Philips Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 123. Philips Recent Development
 Table 124. GE Healthcare Company Details
 Table 125. GE Healthcare Business Overview
 Table 126. GE Healthcare Intelligent Cancer Care (ICC) Product
 Table 127. GE Healthcare Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 128. GE Healthcare Recent Development
 Table 129. Azra AI Company Details
 Table 130. Azra AI Business Overview
 Table 131. Azra AI Intelligent Cancer Care (ICC) Product
 Table 132. Azra AI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 133. Azra AI Recent Development
 Table 134. Path AI Company Details
 Table 135. Path AI Business Overview
 Table 136. Path AI Intelligent Cancer Care (ICC) Product
 Table 137. Path AI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 138. Path AI Recent Development
 Table 139. NVIDIA Company Details
 Table 140. NVIDIA Business Overview
 Table 141. NVIDIA Intelligent Cancer Care (ICC) Product
 Table 142. NVIDIA Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 143. NVIDIA Recent Development
 Table 144. ConcertAI Company Details
 Table 145. ConcertAI Business Overview
 Table 146. ConcertAI Intelligent Cancer Care (ICC) Product
 Table 147. ConcertAI Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 148. ConcertAI Recent Development
 Table 149. Digital Diagnostics Company Details
 Table 150. Digital Diagnostics Business Overview
 Table 151. Digital Diagnostics Intelligent Cancer Care (ICC) Product
 Table 152. Digital Diagnostics Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 153. Digital Diagnostics Recent Development
 Table 154. Median Technologies Company Details
 Table 155. Median Technologies Business Overview
 Table 156. Median Technologies Intelligent Cancer Care (ICC) Product
 Table 157. Median Technologies Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 158. Median Technologies Recent Development
 Table 159. BioNTech SE Company Details
 Table 160. BioNTech SE Business Overview
 Table 161. BioNTech SE Intelligent Cancer Care (ICC) Product
 Table 162. BioNTech SE Revenue in Intelligent Cancer Care (ICC) Business (2020-2025) & (US$ Million)
 Table 163. BioNTech SE Recent Development
 Table 164. Research Programs/Design for This Report
 Table 165. Key Data Information from Secondary Sources
 Table 166. Key Data Information from Primary Sources
 Table 167. Authors List of This Report


List of Figures
 Figure 1. Intelligent Cancer Care (ICC) Picture
 Figure 2. Global Intelligent Cancer Care (ICC) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intelligent Cancer Care (ICC) Market Share by Type: 2024 VS 2031
 Figure 4. Cancer Prevention and Screening Features
 Figure 5. AI-Assisted Diagnosis Features
 Figure 6. Prediction of Treatment Outcome Features
 Figure 7. Intelligent Radiation Oncology Features
 Figure 8. Tele-Oncology Features
 Figure 9. Global Intelligent Cancer Care (ICC) Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Intelligent Cancer Care (ICC) Market Share by Application: 2024 VS 2031
 Figure 11. Breast Cancer Case Studies
 Figure 12. Lung Cancer Case Studies
 Figure 13. Prostate Cancer Case Studies
 Figure 14. Colorectal Cancer Case Studies
 Figure 15. Brain Tumor Case Studies
 Figure 16. Others Case Studies
 Figure 17. Intelligent Cancer Care (ICC) Report Years Considered
 Figure 18. Global Intelligent Cancer Care (ICC) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Intelligent Cancer Care (ICC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Intelligent Cancer Care (ICC) Market Share by Region: 2024 VS 2031
 Figure 21. Global Intelligent Cancer Care (ICC) Market Share by Players in 2024
 Figure 22. Global Top Intelligent Cancer Care (ICC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Cancer Care (ICC) as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Intelligent Cancer Care (ICC) Revenue in 2024
 Figure 24. North America Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Intelligent Cancer Care (ICC) Market Share by Country (2020-2031)
 Figure 26. United States Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Intelligent Cancer Care (ICC) Market Share by Country (2020-2031)
 Figure 30. Germany Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Intelligent Cancer Care (ICC) Market Share by Region (2020-2031)
 Figure 38. China Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Intelligent Cancer Care (ICC) Market Share by Country (2020-2031)
 Figure 46. Mexico Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Intelligent Cancer Care (ICC) Market Share by Country (2020-2031)
 Figure 50. Turkey Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Intelligent Cancer Care (ICC) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Varian (Siemens) Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 54. CityCancerChallenge Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 55. Canon Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 56. VieCure Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 57. Sophia Genetics Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 58. Freenome Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 59. Pfizer Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 60. IBM Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 61. Sanofi Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 62. GSK Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 63. Roche Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 64. Exscientia Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 65. BenevolentAI Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 66. Bayer Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 67. Philips Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 68. GE Healthcare Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 69. Azra AI Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 70. Path AI Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 71. NVIDIA Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 72. ConcertAI Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 73. Digital Diagnostics Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 74. Median Technologies Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 75. BioNTech SE Revenue Growth Rate in Intelligent Cancer Care (ICC) Business (2020-2025)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Intelligent Contact Center ICC Market
Global Intelligent Radiotherapy Overall Solution Market Research Report 2024
Global Artificial Intelligence AI in Cancer Market Research Report 2024
Global Intelligent and Health Care for the Old Market Research Report 2024
Global Intelligent Command and Control Center Market Research Report 2024
Global Integrated Cancer Care Management Service Platform Market Research Report 2024
AI In Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Immunotherapy Market
Global Next Generation Oncology Solution Market Research Report 2024
Global Intelligent Radiotherapy Positioning Products Market Research Report 2024
Artificial Intelligence AI in Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intensity Modulated Radiation Therapy Market Research Report 2024
Global Tumor Registry Software Market Research Report 2024
Interactive Patient Care Systems IPC Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immuno Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Custom ICC Profiling Service Market Research Report 2025
Cancer Cell Analysis Market
Global Medical Intelligent Triage Market Research Report 2025
Global Breast Intelligent Analysis System Market Research Report 2024
Global Intelligent Clinical Trials Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions